InvestorsHub Logo
Followers 8
Posts 2018
Boards Moderated 0
Alias Born 07/19/2006

Re: None

Thursday, 04/06/2017 8:55:25 PM

Thursday, April 06, 2017 8:55:25 PM

Post# of 2099
Anyone listen to the KOL to today? Interesting, but very, very complicated. It will take a while to digest the new target. It appears there is potential in both oncology but also immune mediated disease as well if I understood the broad strokes. They are reaching out to the Parker Institute for further expertise and only disclosed the program recently because they finalized the patenting issues.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News